Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice

CB2: a cannabinoid receptor with an identity crisis

(2010) Brady K Atwood et al.   BRITISH JOURNAL OF PHARMACOLOGY

Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors

(2010) MS García-Gutiérrez et al.   BRITISH JOURNAL OF PHARMACOLOGY

Constitutive Genetic Deletion of the Growth Regulator Nogo-A Induces Schizophrenia-Related Endophenotypes

(2010) R. Willi et al.   JOURNAL OF NEUROSCIENCE

Serotonin Modulates Fast-Spiking Interneuron and Synchronous Activity in the Rat Prefrontal Cortex through 5-HT1A and 5-HT2A Receptors

(2010) M. V. Puig et al.   JOURNAL OF NEUROSCIENCE

Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice

(2010) María S García-Gutiérrez et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Motor behavior abnormalities in drug-naïve patients with schizophrenia spectrum disorders

(2010) Victor Peralta et al.   MOVEMENT DISORDERS

Effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in Japanese chronic schizophrenia

(2010) Taro Kishi et al.   PSYCHOPHARMACOLOGY

Behavioral Effects of CB2 Cannabinoid Receptor Activation and Its Influence on Food and Alcohol Consumption

(2009) E. S. Onaivi et al.   Annals of the New York Academy of Sciences

A Reverse-Translational Study of Dysfunctional Exploration in Psychiatric Disorders

(2009) William Perry et al.   ARCHIVES OF GENERAL PSYCHIATRY

Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice

(2009) Susan B. Powell et al.   BEHAVIOURAL PHARMACOLOGY

Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions

(2009) Maria T.G. Perona et al.   BEHAVIOURAL PHARMACOLOGY

Mutant models for genes associated with schizophrenia

(2009) Lieve Desbonnet et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Brain Cannabinoid CB2 Receptor in Schizophrenia

(2009) Hiroki Ishiguro et al.   BIOLOGICAL PSYCHIATRY

Anti-depressant and anxiolytic like behaviors in PKCI/HINT1 knockout mice associated with elevated plasma corticosterone level

(2009) Elisabeth Barbier et al.   BMC NEUROSCIENCE

Further pharmacological characterization of 5-HT2C receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo

(2009) P Quérée et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabis use and age of diagnosis of schizophrenia

(2009) Gisela Sugranyes et al.   EUROPEAN PSYCHIATRY

Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia

(2009) T. B. Halene et al.   GENES BRAIN AND BEHAVIOR

Prepulse inhibition of the startle response with chronic schizophrenia: A replication study

(2009) Masatsugu Moriwaki et al.   NEUROSCIENCE RESEARCH

Modulation of prepulse inhibition through both M1 and M4 muscarinic receptors in mice

(2009) Morgane Thomsen et al.   PSYCHOPHARMACOLOGY

Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice

(2009) David Delotterie et al.   PSYCHOPHARMACOLOGY

Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment

(2009) Leyre Urigüen et al.   PSYCHOPHARMACOLOGY

The relationship between prepulse inhibition and general psychopathology in patients with schizophrenia treated with long-acting risperidone

(2009) Isabel Martinez-Gras et al.   SCHIZOPHRENIA RESEARCH

Behavioral abnormalities in synapsin II knockout mice implicate a causal factor in schizophrenia

(2009) Bailee A. Dyck et al.   SYNAPSE

Phenotypic characterization of mice heterozygous for a null mutation of glutamate carboxypeptidase II

(2009) Liqun Han et al.   SYNAPSE

Abnormal social behavior, hyperactivity, impaired remote spatial memory, and increased D1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockout mice

(2009) Koichi Tanda et al.   Molecular Brain

Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia

(2008) Satoko Hattori et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis

(2008) Celia J. A. Morgan et al.   BRITISH JOURNAL OF PSYCHIATRY

Mechanisms of Control of Neuron Survival by the Endocannabinoid System

(2008) Ismael Galve-Roperh et al.   CURRENT PHARMACEUTICAL DESIGN

Mice lacking the schizophrenia-associated protein FEZ1 manifest hyperactivity and enhanced responsiveness to psychostimulants

(2008) Nobutaka Sakae et al.   HUMAN MOLECULAR GENETICS

Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia

(2008) Masashi Ikeda et al.   HUMAN MOLECULAR GENETICS

Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-d-aspartic acid receptor up-regulation

(2008) Laura Gray et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain

(2008) I. Racz et al.   JOURNAL OF NEUROSCIENCE

A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner

(2008) Maria Beatriz Goncalves et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Endocannabinoid signaling as a synaptic circuit breaker in neurological disease

(2008) István Katona et al.   NATURE MEDICINE

The stop null mice model for schizophrenia displays cognitive and social deficits partly alleviated by neuroleptics

(2008) M. Bégou et al.   NEUROSCIENCE

A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition

(2008) M. Kvajo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories

(2008) S. N. Iyer et al.   PSYCHOLOGICAL MEDICINE

Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders

(2008) Nobuyuki Yamasaki et al.   Molecular Brain